PHGDH-inactive

CAS No. 1914971-16-6

PHGDH-inactive( —— )

Catalog No. M27683 CAS No. 1914971-16-6

PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
5MG 30 In Stock
10MG 52 In Stock
25MG 113 In Stock
50MG 178 In Stock
100MG 256 In Stock
200MG 359 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PHGDH-inactive
  • Note
    Research use only, not for human use.
  • Brief Description
    PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
  • Description
    PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hCE2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1914971-16-6
  • Formula Weight
    327.45
  • Molecular Formula
    C17H21N5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (254.48 mM)
  • SMILES
    Cc1cc(C)nc(NC(=S)N2CCN(CC2)c2ccncc2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhen-Peng Mai, et al. Biotransformation of alisol G by Penicillium janthinellum and the hCE2 inhibitory effects of its metabolites. Phytochemistry Letters, Volume 13, September 2015, Pages 228–233.
molnova catalog
related products
  • Erythorbic Acid

    Erythorbic Acid is an antiscorbutic agent.

  • Actinodaphine

    Actinodaphnine is a natural product.

  • Tozorakimab

    Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting IL-33. It inhibits IL-33 signaling through ST2 and RAGE/EGFR, reduces inflammation and epithelial dysfunction, and can be used to study chronic obstructive pulmonary disease.